| Literature DB >> 7507693 |
J A Radford1, S Clark, D Crowther, S M Shalet.
Abstract
Semen analysis was performed in 14 men a median of 13.5 months after completion of VAPEC-B chemotherapy for Hodgkin's disease or non-Hodgkin's lymphoma. Semen from 12 patients contained motile spermatozoa, and in nine cases the count was > 20 million ml-1. One patient was azoospermic (VAPEC-B followed by pelvic radiotherapy) and another had a count of 21 million ml-1 but sperm were non-motile. These findings suggest that, in the majority of cases, VAPEC-B chemotherapy does not cause permanent damage to the male germinal epithelium. A more detailed study of gonadal function in males and females before and after treatment with VAPEC-B for Hodgkin's disease is currently in progress.Entities:
Mesh：
Substances：
Year: 1994 PMID： 7507693 PMCID： PMC1968681 DOI： 10.1038/bjc.1994.69
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640